Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma

Oncology Letters
Dehai WuSheng Tai

Abstract

Hepatitis B virus (HBV) infection is a risk factor for hepatocellular carcinoma (HCC). HBV X protein (HBx) is an important carcinogen for HBV-induced HCC. When the HBx gene is integrated into the host cell genome, it is difficult to eradicate. The identification of an effective target to inhibit the oncogenic function of HBx is therefore critically important. The present study demonstrated that HBx, particularly truncated HBx, was expressed in several HBV-derived cell lines (e.g., Hep3B and SNU423). By analyzing data from The Cancer Genome Atlas, it was revealed that high expression of high mobility group box 1 (HMGB1) was associated with the process and prognosis of HCC. In vitro experiments confirmed that HBx could regulate the expression of HMGB1 and knockdown of HMGB1 could decrease the ability of HBx to promote cellular proliferation. HBx could also upregulate six transcription factors (GATA binding protein 3, Erb-B2 receptor tyrosine kinase 3, heat shock transcription factor 1, nuclear factor κB subunit 1, TATA-box binding protein and Kruppel-like factor 4), which could directly regulate HMGB1. By analyzing genes that are co-expressed with HMGB1, several signaling pathways associated with the development of HCC were ident...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 26, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·B-Q ChengY-Q Li
Oct 25, 2008·Journal of Molecular Biology·Laura CatoJean O Thomas
Sep 8, 2010·The Journal of Cell Biology·Daolin TangMichael T Lotze
Mar 5, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Qing LinShao Bo Su
Mar 30, 2011·Journal of the American Chemical Society·Kyoko FuruitaChojiro Kojima
Nov 15, 2012·Molecular and Cellular Biology·Cheryl ChanCaroline G Lee
Jan 15, 2013·Gastroenterology·Virginia Hernandez-GeaJosep M Llovet
Jan 1, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hai HuangAllan Tsung
Jan 16, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Shao Hui TangXiang Wu Jiang
Aug 12, 2014·Molecular Medicine·Rui KangDaolin Tang
Sep 11, 2014·World Journal of Gastroenterology : WJG·Mirko TarocchiAndrea Galli
Jun 3, 2015·World Journal of Gastroenterology : WJG·Shan-Long DingFeng-Min Lu
Oct 20, 2015·World Journal of Gastroenterology : WJG·Ming GengXiao-Hong Liu
Mar 28, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Hongwei ZhuXiao Yu
Apr 17, 2016·Journal of Hepatology·Massimo Levrero, Jessica Zucman-Rossi
Apr 4, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Samer TohmeAllan Tsung

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
X-ray
transfection

Software Mentioned

Targetscan
Prism
Toppgene
Genecards
R2

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.